Michel is a serial entrepreneur in the field of Medical Technology, Cell Therapy and Digital Health. He has held a number of co-founder or executive positions in several ventures.
Michel Lussier serves as Chairman of the Board of Directors. Michel is a serial entrepreneur in the field of Medical Technology, Cell Therapy and Digital Health. He has held a number of co-founder or executive positions in several ventures. Michel is also Chairman of the board and co-founder of Celyad, a NASDAQ and Euronext listed bio-technology company based in Mont-Saint-Guibert, Belgium as well as Gabi Smart Care SA, a Belgium early Stage medical wearable company developing patient-centric digital solution with personalized data and predictions to improve children’s care (better monitoring, diagnosis, and prevention).
Michel is also a board member of Occlutech AG, a Swedish / Swiss company developing, manufacturing, and commercializing structural heart and interatrial shunt products, addressing congenital heart defects, stroke prevention and heart failure. Michel also founded and led Medpole since 2002, a consulting firm helping early stage European and North-American companies in their development. Since May 2014 and until September 2020, Mr. Lussier has also served as the Chief Executive Officer of Metronom Health Inc, an early stage medical device company founded by Fjord Ventures, developing a continuous glucose monitoring system.
Prior to that, from 2002 to 2013, he worked for Volcano Corporation, where he served several positions, most recently as President, Clinical and Scientific Affairs from 2012 to 2013, and prior to that from 2007 to 2012, Group President, Advanced Imaging Systems, Global Clinical & Scientific Affairs and General Management of Europe, Africa and the Middle East. Mr. Lussier obtained a Bachelor of Sciences degree in Electrical Engineering and Master’s Degree in Biomedical Engineering at the University of Montreal. He also holds an MBA from INSEAD (European Institute of Business Administration), France. In addition to serving on the Company’s Board of Directors, he also coaches several early stage medical devices companies.